Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

MBX Biosciences, Inc. (MBX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

MBX Biosciences, Inc. (MBX), most recent 12 months reported: net loss $104.29M, free cash flow -$85.2M. Latest balance sheet on file: liquid cash $418.58M. From SEC filings. Others in Pharmaceutical Preparations: MAIA Biotechnology, Inc. · Veradermics, Inc · MUSTANG BIO, INC. · Moleculin Biotech, Inc. · MEDICUS PHARMA LTD. · Jyong Biotech Ltd. · MIRA Pharmaceuticals, Inc. · Milestone Pharmaceuticals Inc.

Stock screener

Watchlist